Horizon Europe Cluster 1 — Health (HLTH)
Supports Horizon Europe Cluster 1 Health initiatives that strengthen a competitive and sustainable European health industry through innovation.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.
Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.
Funds safer medication management using biomarkers, clinical data and decision support.
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.
Funds implementation research that helps children and young people prevent and manage chronic disease equitably.
Funds climate-health exposome research linking lifelong exposures, disease burden, vulnerability and resilience.
Funds four €4–5M PCP projects that help healthcare systems and communities adapt to climate-related health risks.
Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.
Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
Funds €10–12M projects that make Virtual Human Twins useful for prevention, diagnosis and safer clinical decisions.
Funds a European community and roadmap for trustworthy frontier AI models in healthcare.